EULAR Advocacy Committee
The EULAR Advocacy Committee engages with the EU as well as other national political institutions as a recognised partner and source of expertise in rheumatic and musculoskeletal diseases. The Committee fights for the recognition of the needs of people with rheumatic and musculoskeletal diseases (RMDs) by advocating research and education in rheumatology, promoting the EULAR brand as a reliable source of information, coordinating the work of the Sub-Committee(s) (Communication), and providing strategic guidance on all EULAR messages to internal and external audiences.
Communications Sub-Committee By-Laws
Chair Prof. Loreto Carmona, Spain
Chair-elect To be announced
Committee members
Daniel Aletaha, Austria
Tadej Avcin, Slovenia
Ayhan Dinc, Turkey
Andrea Domjan, Hungary
Katie Druce, United Kingdom
Fernando Estevez-Lopez, Spain
Laure Gossec, France
Rikke Helene Moe, Norway
Oliver Hendricks, Denmark
Manouk de Hooge, Luxembourg
Annamaria Iagnocco, Italy
Margreet Kloppenburg, Netherlands
Elsa Mateus, Portugal
Iain McInnes, United Kingdom
Polina Pchelnikova, Russia
Andri Phoka, Cyprus
Laura Pirila, Finland
Paul Studenic, Austria
Zoltan Szekanecz, Hungary
Lidia Teixeira, Portugal
Thea Vliet-Vlieland, Netherlands
Anna Voormann, Germany
EULAR Communications Sub-Committee
The Communications Sub-Committee supports EULAR's and the Committee's objective and has the following aims:
- provide strategic advice on EULAR communications, such as the EULAR communication plan, website and other digital communications, PR campaigns, EULAR App and emerging products;
- provide strategic advice on all aspects regarding the official EULAR publications, (e.g. Annals of the Rheumatic Diseases and RMD Open), such as policies in academic publishing, advertising, applications for Editor of each journal, contract with the publisher, ethical policies (e.g. duplicate publication, plagiarism, conflict of interest, etc.).
The Sub-Committee does not pursue gainful or self-help purposes.
Sub-Committee Chair: Dr. Elena Nikiphorou
Related Information
About EULAR Advocacy
EU Advocacy is a key activity for a European umbrella organisation like the European Alliance of Associations for Rheumatology (EULAR).
EULAR Advocacy Partnerships
EULAR is committed to partner with organisations and scientific medical societies at a EU and national level towards improving research funding, social policy legislation and quality of care; assisting advocacy actions on the national and international levels around rheumatic and musculoskeletal diseases (RMDs).
EULAR RheumaMap
A Research Roadmap to transform the lives of people with Rheumatic and Musculoskeletal Diseases.
EULAR Policy Statements
As part of its advocacy activities, EULAR produces and adopts a number of documents and declarations that are used to express EULAR’s position and/or demands on different policy issues.
EU Parliament Interest Group on RMDs
The European Parliament Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs) was created in 2009 on the occasion of World Arthritis Day (12 October) and was re-established during the current parliamentary term (2014-2019).
Links to other organisations
Partnerships that help to increase the knowledge of the organisations involved and the impact they can have on the political stage.
Questions and Answers on RMDs
EULAR description on Rheumatic and Musculoskeletal Diseases (RMDs)
See more
EULAR Statutes, Reports, and By-Laws
The official statutes of the European Alliance of Associations for Rheumatology, EULAR
EULAR Committees
Established by the Board, Committees are set up to manage and perform the various activities of EULAR on behalf of the Council.
